GLOBOCAN 2012

The International Agency for Research on Cancer (IARC) is the specialized cancer agency of the World Health Organization.

The aim of the project is to provide contemporary estimates of the incidence of, mortality and prevalence from major types of cancer, at national level, for 184 countries of the world. The GLOBOCAN estimates are presented for 2012, separately for each sex. 1-, 3- and 5-year prevalence data are available for the adult population only (ages 15 and over). Please note that:

  1. These estimates are based on the most recent data available at IARC and on information publically available on the Internet, but more recent figures may be available directly from local sources.
  2. Because the sources of data are continuously improving in quality and extent, estimates may not be truly comparable overtime and care should be taken when comparing these estimates with those published earlier. The observed differences may be the result of a change in the methodology and should not be interpreted as a time trend effect.
Data creator
International Agency for Research on Cancer (IARC)
Date of creation
2012
Distributor
Lyon: International Agency for Research on Cancer (IARC)
Statistics type
Subjects
Geography
Notes

IARC has proprietary rights to the materials on the Website. Publications/data made available by IARC/WHO enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights are reserved. Materials (fact sheets, maps, estimates or data) may be used "as is" for research, educational or other non-commercial purposes, but the corresponding referencemust be cited in all cases. Requests for any other use, including, but not limited to, use in conjunction with commercial purposes, should be addressed to publications@iarc.fr. Systematic retrieval of data to create or compile, directly or indirectly, a collection, database or directory without explicit prior written permission from IARC is prohibited.

Access status
Open
Access conditions and restrictions

See notes for details